Company Filing History:
2 out of 5,450 
1 out of 1,209 
Years Active: 2008-2017
Title: Jun Yao: Innovator in Cancer Research
Introduction
Jun Yao is a prominent inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of cancer research, particularly in the areas of gene methylation and the prognosis of hyperproliferative diseases. With a total of 3 patents, his work has the potential to impact cancer diagnosis and treatment.
Latest Patents
One of Jun Yao's latest patents focuses on gene methylation and expression. This invention provides a method for analyzing the methylation status of all or part of an entire genome. It also features methods and reagents for characterizing biological cells containing DNA that is susceptible to methylation. These methods include diagnosing cancer, such as breast cancer. Another significant patent addresses the over-expression of 14-3-3 zeta as a poor prognosis factor and a therapeutic target in multiple cancer types. This patent discloses methods for determining prognosis in subjects with hyperproliferative diseases by assessing the expression and/or function of 14-3-3 zeta. Additionally, it outlines the creation of pharmaceutical agents that modulate apoptosis, which can be used in treating hyperproliferative diseases, including cancer.
Career Highlights
Jun Yao has worked with esteemed institutions such as the University of Texas System and Dana-Farber Cancer Institute. His research has been pivotal in advancing our understanding of cancer biology and therapeutic strategies.
Collaborations
Throughout his career, Jun Yao has collaborated with notable colleagues, including Dihua Yu and Christopher L Neal. These partnerships have further enriched his research and contributions to the field.
Conclusion
Jun Yao's innovative work in cancer research exemplifies the critical role of inventors in advancing medical science. His patents and collaborations highlight the importance of continued research in the fight against cancer.